Bio-IT World

See the following -

Bio-IT World Announces the Winners of Its Tenth Annual Best Practices Awards

Press Release | Bio-IT World, Cambridge Healthtech Institute (CHI) | April 30, 2014

Bio-IT World announced the winners of its tenth annual Best Practices Awards competition this morning in a plenary session at the 2014 Bio-IT World Conference & Expo in Boston. Grand prize winners were named in five life sciences categories highlighting best practices in clinical trial IT, research infrastructure, bioinformatics, cloud computing and data management from AstraZeneca and Tessella, U-BIOPRED, the Pistoia Alliance, Baylor College of Medicine, and Genentech. Read More »

Opscode Named Best of Show at Bio-IT World 2012

Press Release | Opscode | May 7, 2012

Opscode®, the leader in cloud infrastructure automation, today announced that Opscode Chef™, its leading systems-integration framework, was named "Best of Show" at Bio-IT World Conference and Expo in the event's Information Technology (IT) Infrastructure category. Read More »

Pistoia Alliance Wins Bio-IT World Grand Prize-Continues Innovation Mission

I received an email newsletter this morning from the Pistoia Alliance and it was so full of information and updates that I decided to post the entire newsletter as an article. A note on the Pistoia Alliance is long overdue. I had meant to write an article on the Alliance back in April after the 2014 Bio-IT World conference organizers announced that Pistoia's HELM project had been chosen as one of the Grand prize winners. Read More »

Universal Language: The Pistoia Alliance Takes on Indescribable Biology

Best Practices WinnerThe Pistoia Alliance has previously sponsored new methods for querying databases and the scientific literature, and a more effective algorithm for compressing and sharing genetic sequencing data. Over the past year, another Pistoia project, HELM, has entered the public domain after gradual development by an assortment of Alliance members. An open source language and set of editing tools for working with large biomolecules, HELM has already become a foundational part of research in at least three large pharmaceutical companies. Read More »